Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 59% ± 22% | |
GABAergic neuron | 10 studies | 46% ± 18% | |
retinal cone cell | 7 studies | 76% ± 23% | |
interneuron | 6 studies | 60% ± 20% | |
neuron | 5 studies | 53% ± 22% | |
GABAergic interneuron | 3 studies | 56% ± 16% | |
granule cell | 3 studies | 39% ± 22% | |
GABAergic amacrine cell | 3 studies | 48% ± 15% | |
glycinergic amacrine cell | 3 studies | 52% ± 15% | |
amacrine cell | 3 studies | 56% ± 24% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 41% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 100% | 153.29 | 241 / 241 | 0% | 0 | 0 / 0 |
brain | 68% | 122.99 | 1805 / 2642 | 25% | 0.79 | 179 / 705 |
pancreas | 57% | 21.01 | 186 / 328 | 22% | 0.71 | 39 / 178 |
esophagus | 62% | 77.21 | 895 / 1445 | 8% | 0.34 | 15 / 183 |
adrenal gland | 10% | 5.35 | 27 / 258 | 59% | 6.96 | 135 / 230 |
blood vessel | 55% | 38.86 | 729 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.11 | 16 / 45 |
lung | 23% | 7.72 | 135 / 578 | 10% | 0.57 | 115 / 1155 |
stomach | 30% | 9.49 | 109 / 359 | 2% | 0.12 | 5 / 286 |
intestine | 28% | 7.36 | 267 / 966 | 2% | 0.14 | 13 / 527 |
ovary | 1% | 0.18 | 1 / 180 | 27% | 0.72 | 117 / 430 |
breast | 15% | 5.97 | 70 / 459 | 5% | 0.24 | 61 / 1118 |
adipose | 19% | 9.19 | 227 / 1204 | 0% | 0 | 0 / 0 |
bladder | 14% | 3.05 | 3 / 21 | 4% | 0.31 | 21 / 504 |
uterus | 1% | 0.52 | 1 / 170 | 10% | 0.28 | 45 / 459 |
thymus | 2% | 0.57 | 13 / 653 | 7% | 0.22 | 45 / 605 |
kidney | 4% | 1.35 | 4 / 89 | 4% | 0.14 | 37 / 901 |
prostate | 5% | 1.38 | 12 / 245 | 0% | 0.01 | 2 / 502 |
skin | 1% | 0.31 | 21 / 1809 | 0% | 0.02 | 2 / 472 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
heart | 0% | 0.07 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006940 | Biological process | regulation of smooth muscle contraction |
GO_0051260 | Biological process | protein homooligomerization |
GO_0006813 | Biological process | potassium ion transport |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0001508 | Biological process | action potential |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0043204 | Cellular component | perikaryon |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_0016020 | Cellular component | membrane |
GO_0030425 | Cellular component | dendrite |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005251 | Molecular function | delayed rectifier potassium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KCNB2 |
Protein name | Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2) |
Synonyms | |
Description | FUNCTION: Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain and smooth muscle cells. Channels open or close in response to the voltage difference across the membrane, letting potassium ions pass in accordance with their electrochemical gradient. Homotetrameric channels mediate a delayed-rectifier voltage-dependent outward potassium current that display rapid activation and slow inactivation in response to membrane depolarization. Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNB1; channel properties depend on the type of alpha subunits that are part of the channel. Can also form functional heterotetrameric channels with other alpha subunits that are non-conducting when expressed alone, such as KCNS1 and KCNS2, creating a functionally diverse range of channel complexes. In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes, making it difficult to assign currents observed in intact tissues to any particular potassium channel family member. Contributes to the delayed-rectifier voltage-gated potassium current in cortical pyramidal neurons and smooth muscle cells. . |
Accessions | ENST00000523207.2 Q92953 |